Evidence map›Paper›PMID 31295307›Full record

ArticlePloS one2019

Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines.

Elaine Stur, Andrés Felipe Aristizabal-Pachon, Kamila Chagas Peronni, Lidiane Pignaton Agostini, Sabine Waigel, Julia Chariker, Donald M Miller, Shelia Dian Thomas, Francine Rezzoug, Raquel Spinassé Detogni and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Elaine SturPrograma de Pós-graduação em Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brasil.ORCID 0000-0001-5962-0050
Andrés Felipe Aristizabal-PachonDepartment of Genetics at Ribeirão Preto Medical School, and Center for Medical Genomics - HCRP, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.ORCID 0000-0003-3004-4867
Kamila Chagas PeronniDepartment of Genetics at Ribeirão Preto Medical School, and Center for Medical Genomics - HCRP, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Lidiane Pignaton AgostiniPrograma de Pós-graduação em Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brasil.
Sabine WaigelMolecular Targets Program, JG Brown Cancer Center, University of Louisville, Louisville, Kentucky.
Julia CharikerDepartment of Computer Engineering and Computer Science, Speed School of Engineering, University of Louisville, Kentucky, United States of America.
Donald M MillerJames Graham Brown Cancer Center, Department of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Shelia Dian ThomasJames Graham Brown Cancer Center, Department of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Francine RezzougJames Graham Brown Cancer Center, Department of Medicine, University of Louisville, Louisville, Kentucky, United States of America.
Raquel Spinassé DetogniPrograma de Pós-graduação em Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brasil.
Raquel Silva Dos ReisPrograma de Pós-graduação em Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brasil.
Wilson Araujo Silva JuniorDepartment of Genetics at Ribeirão Preto Medical School, and Center for Medical Genomics - HCRP, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Iuri Drumond LouroPrograma de Pós-graduação em Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brasil.
Universidade Federal do Espírito Santo · BRUniversity of Louisville · USUniversidade de São Paulo · BR

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
PILOT PROJECT PROGRAMP30GM106396 · NIGMS · UNIVERSITY OF LOUISVILLE · PI MILLER, DONALD M. · 2013 to 2017
$5.4M
NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P30 GM106396
6 · The paper itself

Abstract

Glyphosate is a broad-spectrum herbicide that is used worldwide. It represents a potential harm to surface water, and when commercially mixed with surfactants, its uptake is greatly magnified. The most well-known glyphosate-based product is Roundup. This herbicide is potentially an endocrine disruptor and many studies have shown the cytotoxicity potential of glyphosate-based herbicides. In breast cancer (BC) cell lines it has been demonstrated that glyphosate can induce cellular proliferation via estrogen receptors. Therefore, we aimed to identify gene expression changes in ER+ and ER- BC cell lines treated with Roundup and AMPA, to address changes in canonical pathways that would be related or not with the ER pathway, which we believe could interfere with cell proliferation. Using the Human Transcriptome Arrays 2.0, we identified gene expression changes in MCF-7 and MDA-MB-468 exposed to low concentrations and short exposure time to Roundup Original and AMPA. The results showed that at low concentration (0.05% Roundup) and short exposure (48h), both cell lines suffered deregulation of 11 canonical pathways, the most important being cell cycle and DNA damage repair pathways. Enrichment analysis showed similar results, except that MDA-MB-468 altered mainly metabolic processes. In contrast, 48h 10mM AMPA showed fewer differentially expressed genes, but also mainly related with metabolic processes. Our findings suggest that Roundup affects survival due to cell cycle deregulation and metabolism changes that may alter mitochondrial oxygen consumption, increase ROS levels, induce hypoxia, damage DNA repair, cause mutation accumulation and ultimately cell death. To our knowledge, this is the first study to analyze the effects of Roundup and AMPA on gene expression in triple negative BC cells. Therefore, we conclude that both compounds can cause cellular damage at low doses in a relatively short period of time in these two models, mainly affecting cell cycle and DNA repair.

Indexed as

Breast NeoplasmsCell ProliferationDNA RepairEstrogen Receptor alphaEstrogensFemaleGene Expression Regulation, NeoplasticGlycineGlyphosateHerbicidesHumansMCF-7 CellsSignal TransductionTranscriptomeESR1 protein, humanEstrogen Receptor alphaEstrogensGlycineGlyphosateHerbicides

Identifiers

PMID31295307
PMCPMC6622539
OpenAlexW2960415539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.